NASDAQ
Emergent BioSolutions Inc. (EBS) has a revenue compound annual growth rate of -13.98% over 5 years and 4.26% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.